Abstract

10-Gingerol is a major phenolic lipid found in the rhizomes of ginger (Zingiber officinale). Being amphiphilic in nature, phenolic lipids have the ability to incorporate into cell membranes and modulate membrane properties. The purpose of the present study was to evaluate the effects of 10-gingerol on lipid raft/membrane raft modulation in radio-resistant triple negative breast cancer (MDA-MB-231/IR) cells. The effects of 10-gingerol on MDA-MB-231/IR cells’ proliferation, clonogenic growth, migration, and invasion were assayed using MTT, colony formation, cell migration, and invasion assays, respectively. Sucrose density gradient centrifugation was used to extract lipid rafts. Western blotting and immunofluorescence were employed to assess the effects of 10-gingerol on lipid raft/membrane raft modulation and lipid rafts-associated PI3K/Akt signaling. Cholesterol measurements were carried out using a commercially available kit. 10-gingerol suppressed the proliferation, migration, invasion, and induced apoptosis through targeting the PI3K/Akt signaling pathway in MDA-MB-231/IR cells. Moreover, 10-gingerol was found to modulate the lipid rafts of MDA-MB-231/IR cells and attenuate the key PI3K/Akt signaling components in lipid rafts. The cholesterol content of the lipid rafts and rafts-resident Akt signaling were also affected by exposure to 10-gingerol. The results of the present study highlight rafts-associated PI3K/Akt signaling as a new target of 10-gingerol in MDA-MB-231/IR cells, thus rationalizing a new rafts-mediated treatment approach for radio-resistant triple negative breast cancer cells.

Highlights

  • Breast cancer is the most frequent malignancy in females worldwide and is a molecularly heterogeneous disease [1]

  • We provide experimental evidence that 10-gingerol, a major phytochemical constituent in ginger, can target lipid raft-associated PI3K/Akt signaling through the modulation of lipid rafts, leading to cell death and apoptosis in radio-resistant triple negative breast cancer cells (MDA-MB-231/IR)

  • To assess the inhibitory effects of 10-gingerol on the proliferation of MDA-MB-231/IR cells, cells were exposed to different concentrations (200, 100, 50, 25, 12.5, and 6.25 μM)

Read more

Summary

Introduction

Breast cancer is the most frequent malignancy in females worldwide and is a molecularly heterogeneous disease [1]. Molecular features associated with tumor heterogeneity play a key role in determining treatment plans for breast cancer [2]. Among the breast cancer subtypes, hormone receptor-positive tumors respond to endocrine therapy, while endocrine therapy is not beneficial for triple negative tumors, as they do not express hormone receptors, making it difficult to treat with currently available breast cancer treatments [2]. Breast cancer patients with metastatic disease are mainly treated with chemo- and radiotherapies to enhance the overall survival. Adverse side effects and development resistance after therapy initiation have been identified as major disadvantages of chemo- and radiotherapies. It is of great significance to investigate new anti-breast cancer

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call